- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05900934
The Effects Of Myofascial Release In Combined With Task-Oriented Circuit Training On Balance And Gait In People With Parkinson's Disease
The Effects of Myofascial Release in Combined With Task-oriented Circuit Training on Balance and Gait in People With Parkinson's Disease
In this study, the investigators plan to have Parkinson's patients perform exercises according to the task-oriented training method. Since recent studies have suggested that task-oriented training should be organized as a series of workstations that allow for more intensive practice, each of them has a program content implemented in the form of a station. The program will be implemented in 11 different stations with 3 minutes and a 1-minute break at each station, 3 days a week for 8 weeks under the supervision and guidance of a physiotherapist. The task-oriented training program will be carried out by applying the above-mentioned exercises in the form of stations sequentially within a certain period of time. For all exercises, the intensity perceived by the individuals will be ensured to be 12-15 points of perceived exertion according to the Borg Perceived Exertion Scale. In this way, the exercise program can be easily individualized according to the participant's pain, complaints, and functional status. In the study, after the task-oriented approach, foam roller application and myofascial release will be applied at the end of each session.
Foam roller application; C7-T1 and posterior neck region, thoracic spine, lumbar spine, and right and left sides of the thoracolumbar spine will be applied with a foam roller, which is a myofascial release device, in each session. Each application area will be applied in 3 sets of 60 seconds of application and 30 seconds of rest. The intensity of the pressure for the intensity of the application will be subjectively controlled with a target numeric rating scale rating of 7/10 (0 represents no discomfort and 10 represents maximum discomfort). In the sham group, similar to the literature, the intensity of the application will be applied in accordance with the 0/10 numeric rating scale, at the same application sites, for the same duration and the same rest intervals.
Within the scope of this study, participants gait, balance, rotation time, range of motion, level of achievement of the treatment goal, quality of life and trunk impairment will be evaluated at the beginning of the study and at the end of 8 weeks.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06590
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with "Parkinson's Disease" by a specialist physician,
- In a stable period in terms of motor fluctuations and drug treatment
- Severity of the disease (1-3 according to Hoehn & Yahr) staging
- No other neurological disease
- Cognitive status of 24 and above according to the Mini-Mental State Evaluation (MMSE) test
- No change in Parkinson's disease-related medications or doses during the study
- Volunteering to participate in the study and giving written informed consent
Exclusion Criteria:
- Hearing and visual impairment, orthopedic, cardiopulmonary and additional neurological diseases that prevent participation in exercises
- Lack of independent ambulation
- Using a brain pacemaker for Parkinson's disease
- Continue with another rehabilitation program
- The occurrence of any health problem during the assessments and exercise training
- Failure to attend three consecutive sessions and a total of five sessions during the 24-session treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Myofascial Releasing Group
The intensity of application is important for foam rollers.
For intensity, the intensity of the pressure will be determined by a subjective 7/10 target numeric rating scale rating (0 representing no discomfort and 10 representing maximum discomfort) and applied at the end of each session.
|
Using a subjective 7/10 target numeric rating scale rating (0 representing no discomfort and 10 representing maximum discomfort), the intensity of foam roller application can be determined.
This intensity defines an application intensity that is mildly painful for the participant and appropriate according to previous literature.
Other Names:
|
|
Sham Comparator: Sham Myofascial Releasing Group
In the sham group, similar to the literature, the intensity will be applied with foam rollers in accordance with the 0/10 numerical rating scale, to the same application areas, for the same duration and with the same rest intervals.
|
The severity of the application is not felt at all according to the numerical rating scale of 0/10.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
GAITRite® gait system
Time Frame: Eight week
|
Evaluation of time-distance characteristics of gait
|
Eight week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of Motion Assessment
Time Frame: Baseline- End of the eight week
|
Neck flexion, extension, rotation, lateral flexion, trunk flexion, extension, rotation, lateral flexion and ankle dorsiflexion ROM will be measured.
|
Baseline- End of the eight week
|
|
Berg Balance Scale
Time Frame: Eight week
|
It is used to assess balance in the elderly and to determine the risk of falls.
In the test consisting of 14 items, 0 points are given when the individual cannot perform the activity at all, and 4 points are given when the individual completes the activity independently.
The maximum total score is 56.
0 to 20 points indicate a high risk of falling and impaired balance; 21 to 40 points indicate a moderate risk of falling and acceptable balance.
41 and above indicates good balance and minimal fall risk.
|
Eight week
|
|
Posturographic assessment
Time Frame: Eight week
|
With the Bertec Balance Check ScreenerTM force platform system (BP5050, Bertec Co., Columbus, OH, USA), stability limits in 4 different directions (front, back, right, left) will be evaluated on hard ground with eyes open and hard ground with eyes closed and also on soft ground.
|
Eight week
|
|
The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale
Time Frame: Eight week
|
It evaluates Parkinson's disease in terms of mental and emotional state, motor examination, activities of daily living and treatment complications.
A higher score indicates worse disease severity.
|
Eight week
|
|
Roll-over test
Time Frame: Eight week
|
Both 360-degree turns are timed with a stopwatch.
|
Eight week
|
|
Timed-up and go test
Time Frame: Eight week
|
The timed up-and-go test will be measured without dual-task conditions and with cognitive and motor dual-task conditions.
|
Eight week
|
|
Goal Attainment Scale
Time Frame: Eight week
|
After the treatment, it allows patients to score the extent to which their individual goals have been achieved.
GAS gives individuals the ability to construct their own outcome measures; this is in contrast to measures that are based on a standard set of tasks.
Scoring, however, is performed in a standardised way which in turn allows for statistical analysis.GAS comprises of goals divided into a 5-point scale from -2 to +2.
|
Eight week
|
|
The Parkinson's disease questionnaire-8
Time Frame: Eight week
|
It is an 8-question short form of the 39-item Parkinson's Disease Questionnaire developed specifically for the assessment of quality of life in Parkinson's disease.
|
Eight week
|
|
Trunk impairment scale
Time Frame: Eight week
|
It assesses static and dynamic sitting balance and trunk coordination.
This scale comprises 17 items.
The total score ranges from a minimum of 0 to a maximum 23 points, higher scores indicate better performance.
|
Eight week
|
|
Body-Mass Index
Time Frame: Eight week
|
Participants weight and height will be assessed by investigators and BMI will calculated by investigators.
|
Eight week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yahya Doğan, Dr, Hacettepe University
- Study Chair: Muhammed Kılınç, Prof, Hacettepe University
- Study Chair: Mert Doğan, PhD, Akdeniz University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA-22060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Myofascial Releasing Group
-
Inonu UniversityCompleted
-
Abant Izzet Baysal UniversityCompletedNeck Pain | Trigger Point Pain, MyofascialTurkey
-
Akdeniz UniversityPamukkale UniversityCompletedInvestigation of Acute Effects of Myofascial Trigger Point Release in Women With Chronic Pelvic PainPelvic Pain | Myofascial Trigger Point Pain | Pelvic Floor; RelaxationTurkey
-
Yeditepe UniversityNot yet recruitingAnkle Injuries | Ankle Inversion SprainTurkey
-
Universidad Católica San Antonio de MurciaCompletedLow Back Pain | Trigger Point Pain, MyofascialSpain
-
Eastern Mediterranean UniversityCompletedPremenstrual Syndrome | Chronic Pelvic Pain | Premenstrual PainCyprus
-
Pamukkale UniversityAkdeniz UniversityCompleted
-
Tokat Gaziosmanpasa UniversityNot yet recruiting
-
Riphah International UniversityActive, not recruitingMuscle TightnessPakistan